Effect of gonadotropin-releasing hormone agonist on a uterine arteriovenous malformation

被引：26
|
作者：
Morikawa, Mamoru [1 ]
Yamada, Takashi [1 ]
Yamada, Hideto [1 ]
Minakami, Hisanori [1 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido 0608638, Japan
来源：
OBSTETRICS AND GYNECOLOGY | 2006年 / 108卷 / 03期
关键词：
D O I：
10.1097/01.AOG.0000191584.28717.2c
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
BACKGROUND: The effect of gonadotropin-releasing hormone agonist (GnRHa) on uterine arteriovenous malformations (AVM) is not well known. CASE: A 37-year-old woman with a previous cesarean was diagnosed as having a uterine AVM after a spontaneous abortion with massive vaginal bleeding. The AVM decreased in size from 5.1 x 3.8 cm to 1.4 x 1.0 cm after 6 months of therapy with a GnRHa. Uterine artery embolization conducted after the GnRH therapy resulted in complete disappearance of the AVM. The patient's menstrual cycles and ovulation resumed 3 months after uterine artery embolization. CONCLUSION: Gonadotropin-releasing hormone agonist therapy reduced the size of the uterine AVM. Thus, GnRHa therapy may be useful for uterine AVM in situations where uterine artery embolization must be postponed.
引用
收藏
页码：751 / 753
页数：3
相关论文
共 50 条
  • [31] Depression in women treated with a gonadotropin-releasing hormone agonist
    Toren, P
    Dor, J
    Mester, R
    Mozes, T
    Blumensohn, R
    Rehavi, M
    Weizman, A
    BIOLOGICAL PSYCHIATRY, 1996, 39 (05) : 378 - 382
  • [32] Utilization of gonadotropin-releasing hormone agonist products in adolescents
    Woods, Corinne
    Ho, Amy
    Dutcher, Sarah K.
    Ajao, Adebola
    Hawrusik, Rebecca
    Schoeplein, Ryan
    Moeny, David
    Huang, Ting-Ying
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 319 - 320
  • [33] ENDOMETRIOSIS - TREATMENT WITH GONADOTROPIN-RELEASING HORMONE AGONIST BUSERELIN
    FRANSSEN, AMHW
    KAUER, FM
    CHADHA, DR
    ZIJLSTRA, JA
    ROLLAND, R
    FERTILITY AND STERILITY, 1989, 51 (03) : 401 - 408
  • [34] Luteal phase support with gonadotropin-releasing hormone agonist
    Tsui, Kuan-Hao
    Lin, Li-Te
    Wang, Peng-Hui
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2014, 77 (10) : 505 - 507
  • [35] Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas
    Cramer, SF
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1998, 122 (12) : 1045 - 1045
  • [36] Uterine ultrasonographic changes with gonadotropin-releasing hormone agonists
    Weeks, AD
    Duffy, SRG
    Walker, JJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (01) : 8 - 13
  • [37] Morphometric and electron microscopic analyses of the effect of gonadotropin-releasing hormone agonist treatment on arteriole size in uterine leiomyomas
    Kalir, T
    Wu, HS
    Gordon, RE
    Gil, J
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2000, 124 (09) : 1295 - 1298
  • [38] Gonadotropin-releasing hormone antagonists in the treatment of uterine leiomyoma
    Felberbaum, Ricardo E.
    Kuepker, Wolfgang
    Balogh, Balint
    Diedrich, Klaus
    GYNAKOLOGE, 2020, 53 (08): : 529 - 536
  • [39] Gonadotropin-releasing hormone/gonadotropin-releasing hormone receptor signaling in the placenta
    Sasaki, Kirsten
    Norwitz, Errol R.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2011, 18 (06) : 401 - 408
  • [40] Effect of a gonadotropin-releasing hormone agonist on follicle recruitment and pregnancy rate in cattle
    Schmitt, EJP
    Drost, M
    Diaz, T
    Roomes, C
    Thatcher, WW
    JOURNAL OF ANIMAL SCIENCE, 1996, 74 (01) : 154 - 161
12345